Catalyst Wire Dossier Catalyst Wire Dossier

Rukobia

fostemsavir · ViiV Healthcare
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Rukobia, covering 2017-08-09 to 2025-09-11. Get the full timeline:

Most recent: EMA Authorised: Rukobia (fostemsavir trometamol) — ViiV Healthcare B.V.

See pricing